Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts. As of July 1, 2024, Akili, Inc. operates as a subsidiary of Virtual Therapeutics Corp.
| - | |
| 0.1912-1.25 | |
| 34 097 K | |
| 78 727 K | |
| 1 948 K | |
| -0.12 | |
| 1.727 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
In this article, we discuss Chamath Palihapitiya and the 12 stocks he pumped in the last 10 years. If you want to read about some more Chamath Palihapitiya stocks, go directly to Chamath Palihapitiya ...
Strong strategic and clinical progress in 2023, with multiple catalysts expected in 2024 Launching of two new Founded Entities to advance certain programs from the Wholly Owned Pipeline Robust balan...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
